Arix Bioscience plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Peregrine Moncreiffe, was filed 05 Oct 2022.
Arix Bioscience plc: what insiders have been doing
Arix Bioscience plc is a listed company. Its insiders report their share dealings to RNS (LSE). No insider at Arix Bioscience plc has published a filing in the past twelve months. The most recent one dates from 1 December 2022.
Over the whole record (from 2017), the tally stands at 10 purchases and no sales.
Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
- 636,792 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:4597621
- 100,000 shares@ £1.0294100.0% of flowOutside a trading venueISIN GB00BD045071FCA-NSM:RYDLDHYVAQPLGQCSXARKHQEKCanonical exit: 2 Jan 2023 (T+90)
- 84,000 sharesLondon Stock ExchangeISIN GB00BD045071FCA-NSM:4214871-1Canonical exit: 16 Mar 2022 (T+90)
- 40,000 sharesLondon Stock ExchangeISIN GB00BD045071FCA-NSM:4214871-2Canonical exit: 16 Mar 2022 (T+90)
- 41,666 sharesLondon Stock ExchangeISIN GB00BD045071FCA-NSM:4214871-0Canonical exit: 16 Mar 2022 (T+90)
- 352,335 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:SBLFIPQBSFCSJQQDTTKLQXBG
- 57,803 shares@ £0.865100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:202007010200PR_NEWS_UKDISCLO_0030-3
- 462,428 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:202007010200PR_NEWS_UKDISCLO_0030-0
- 471,676 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:202007010200PR_NEWS_UKDISCLO_0030-1
- 389,133 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:202007010200PR_NEWS_UKDISCLO_0030-2
- 23,255 shares@ £0.86100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:202004170959PR_NEWS_UKDISCLO_0079-0Canonical exit: 15 Jul 2020 (T+90)
- 11,604 shares@ £0.8617100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:202004170959PR_NEWS_UKDISCLO_0079-1Canonical exit: 15 Jul 2020 (T+90)
- 231,348 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_202003160300PR_NEWS_UKDISCLO_0012_20200331164957015_15666
- 373,134 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-0
- 201,492 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-1
- 298,507 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-2
- 111,940 sharesOutside a trading venueISIN GB00BD045071FCA-NSM:PRNRNS_201806111123PR_NEWS_UKDISCLO_0096_20200330111424040_18452-3
- 90,000 shares@ £2.2577.6% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20180321114002_13575710_20200330111427142_9794Canonical exit: 18 Jun 2018 (T+90)
- 55,000 shares@ £2.061100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20170605070004_13248596_20200330131521973_2859-0Canonical exit: 31 Aug 2017 (T+90)
- 26,000 shares@ £2.061100.0% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20170605070004_13248596_20200330131521973_2859-1Canonical exit: 31 Aug 2017 (T+90)
- 28,016 shares@ £2.06122.4% of flowLondon Stock Exchange (XLON)ISIN GB00BD045071FCA-NSM:LSE20170605070004_13248596_20200330131521973_2859-2Canonical exit: 31 Aug 2017 (T+90)
- 569,619 sharesOutside of a trading venueISIN GB00BD045071FCA-NSM:LSE20170530070012_13241449_20200330131531495_22267-0
- 379,746 sharesOutside of a trading venueISIN GB00BD045071FCA-NSM:LSE20170530070012_13241449_20200330131531495_22267-1
- 205,062 sharesOutside of a trading venueISIN GB00BD045071FCA-NSM:LSE20170530070012_13241449_20200330131531495_22267-2
24 of 24 declarations
About Arix Bioscience plc
Arix Bioscience plc is a venture capital company focused on the life sciences sector, investing in innovative companies. It is listed on the London Stock Exchange.
